Teva Pharmaceutical Industries
TEVA
#626
Rank
NZ$65.45 B
Marketcap
NZ$56.91
Share price
-0.63%
Change (1 day)
91.20%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2025 (TTM): NZ$2.13

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$2.05. In 2024 the company made an earnings per share (EPS) of NZ-$2.39 a decrease over its 2023 EPS that were of NZ-$0.84.

EPS history for Teva Pharmaceutical Industries from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.13-188.81%
2024NZ-$2.39184.31%
2023NZ-$0.84-75.94%
2022NZ-$3.50-657.89%
2021NZ$0.63
2019NZ-$1.52-60.34%
2018NZ-$3.83-85.73%
2017NZ-$26.85-23328.57%
2016NZ$0.12-96.2%
2015NZ$3.04-48.6%
2014NZ$5.91138.67%
2013NZ$2.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.15 493.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25 9.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41 66.55%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.06 489.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.83 331.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.22 203.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$1.29-37.21%๐Ÿ‡ฎ๐Ÿ‡ณ India